Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Chrishan S Samuel

Chrishan S Samuel

Monash University,, Australia USA

Mahendra S Rao

Mahendra S Rao

Q Therapeutics, Inc.,, USA USA

Margarita Glazova

Margarita Glazova

Russian Academy of Science,, Russia Russia

Yael Porat

Yael Porat

BioGenCell, Ltd,, Israel Israel

Kenneth K Wu

Kenneth K Wu

National Health Research Institutes and CMU,, Taiwan Taiwan

Thomas Andl

Thomas Andl

University of Central Florida,, USA USA

Helen McGettrick

Helen McGettrick

Helen McGettrick University of Birmingham,, UK UK

Meenakshi Chellaiah

Meenakshi Chellaiah

University of Maryland Dental School,, USA USA

Stem Cell Biology 2018

About conference

 

Hear, Explore and learn the latest research. Present before distinguished global audience. Collaborate, build partnerships and experience Japan. Join the global academic community.

Conference Series Ltd invites all the participants across the globe to attend the 11th World Congress on Stem Cell and Biobanking during August 20-21, 2018 at Tokyo, Japan. Stem Cell Biology 2018 includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Stem Cell Biology 2018 aims in proclaim knowledge and share new ideas amongst the professionals, industrialists and students from research area of Stem Cell and Biobanking to share their research experiences and indulge in interactive discussions at the event. This scientific gathering guarantees that offering the thoughts and ideas will enable and secure you the theme “Novel Insights in Stem Cell and Biobanking”. Stem Cell and Biobanking is the latest trending research in many fields especially in Organ cancer: breast, oral, head and neck Cancer Myeloid, lymphoid leukaemia’ s, cancer treatments etc. The current era fully rolled out with many new advanced treatment technologies. In such case more Stem Cells research institutes were newly introduced within market which obviously shows the market growth of Stem Cells and Biobanking. While analyzing the revenue growth of Stem Cells and Biobanking functions, it highly developed from $150 billion USD to $250 billion USD since from 2010-2015. And the annual growth percentage increases from 20-55 percentages. 

Importance and Scope

Recently, there has been an increasing demand for quality and trained manpower in this evolving branch of biomedicine. As a result of this, stem cells research is emerging as a rage among the many career options available to people in associated fields. The current investment in stem cell research in India is more than 1000 crores. Most of the investment in stem cell research in India is in the government sector. So, there are a lot of research opportunities on a national front in India. 

Why to attend?

With members from around the world focused on learning about Stem Cells and Biobanking, this is your single best opportunity to reach the largest assemblage of participants from the Stem cells research community. Conduct demonstrations, distribute information, acquire knowledge about current and trending Stem cells and Biobanking technologies, make a splash with a new research, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields are hallmarks of this conference.   

Target Audience

  •  Stem cell researchers and academicians
  •  Doctorates in Bio- Sciences
  •  Regenerative medicine Lab Directors/Associates
  •  Professors of Life sciences 
  • Biobanking Researchers
  • Biobanking Faculty
  • Medical Colleges
  • Biobanking Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Cryo storage Companies
  • Data Management Companies
  • Global Biobanking Companies
  • Biobanking investors

Conference Highlights

  • Stem cells
  • Genetics and stem cell biology
  • Cancer stem cells
  • Tissue engineering
  • Stem cell therapy
  • Stem cell transplantation
  • Stem cell niche
  • Regenerative medicine
  • Adult stem cells
  • Embryonic stem cells
  • Stem cell apoptosis and signal transduction
  • Computational biology in stem cells
  • Epigenetics
  • Biobanking
  • Stem cell biomarkers
  • Biobank ethics
  • Stem cell in drug development
  • Cell and gene therapy
  • Stem cell nanotechnology

 

 

 

 

Session/Tracks

Conference series Ltd cordially invites all the scholars from all over world to attend and present their respective scientific research at “11th World Conference On Stem Cell And Biobanking” during August 20-21, Tokyo, Japan which includes prompt Keynote presentations, Oral talks, Poster presentations, Delegate views and Exhibitions.

Theme: “Novel Insights In Stem Cell And Biobanking’’

World conference on Stem Cell Biology 2018 aims in providing premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Stem Cell Biobanking.

Track1. Stem cells

Stem cells are characterized by the ability to self-renew, or divide without senescing, and to differentiate into specialized somatic cells. Stem cells have the ability to differentiate into specific cell types. The two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent that are restricted to becoming a more limited population of cells. Multiple types of stem cells have been identified, including embryonic and adult stem cellsEmbryonic stem cells are pluripotent and can differentiate into all cell types of the mature organism. In contrast, adult (somatic) stem cells, including hematopoietic, muscle, cardiac, neural, and mesenchymal stem cells, are thought to have limited potency, and their differentiated derivatives are generally thought to populate only the tissue of residence. More recent advances in stem cell biology have identified the transcription factors that are sufficient to reprogram somatic cells back to an undifferentiated state. These induced pluripotent stem cells, and other stem cell types, have potential uses for understanding multipotency and self-renewal, developing models of human diseases for drug and toxicology studies, and applying cell-replacement strategies for regenerative medicine.

·      Adult/Somatic stem cells

·      Tissue specific stem cells

·      Pluripotent stem cells

·      Epidermal stem cells

·      Epithelial stem cells

·      Stem cell transcription factors and regulators

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track2. Genetics and stem cell biology

Stem cell genomics analyzes the genomes of stem cells. The study of stem cell genomics has wide reaching implications in the study of stem cell biology and possible therapeutic usages of stem cells. Application of research in this field could lead to drug discovery and information on diseases by the molecular characterization of the pluripotent stem cell through DNA and transcriptome sequencing and looking at the epigenetic changes of stem cells and subsequent products. One step in that process is single cell phenotypic analysis, and the connection between the phenotype and genotype of specific stem cells. 

·      Stem cell genomics

·      Gene knockout

·      Cell potency

·      Stem cell line

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track3. Cancer stem cells

Cancer stem cells are cancer cells (tumor cells) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.

·      Cancer genomics and metabolomics

·      Clinical research in cancer stem cell

·      Biomarker of cancer stem cell

·      Cancer stem cells in brain gliomas

·      Breast cancer stem cell

·      Pancreatic cancer stem cell

·      Lung cancer stem cell

·      Prostate cancer stem cell

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track4. Tissue engineering

Tissue engineering is the use of a combination of cells, engineering and materials methods, and suitable biochemical and physicochemical factors to improve or replace biological tissues. Tissue engineering involves the use of a scaffold for the formation of new viable tissue for a medical purpose. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs. Artificial skin and cartilage are examples of engineered tissues that have been approved by the FDA; however, currently they have limited use in human patients. The term regenerative medicine is often used synonymously with tissue engineering, although those involved in regenerative medicine place more emphasis on the use of stem cells or progenitor cells to produce tissues.

·      Transplantation of engineered cells and tissues

·      Stem cell technology in placental care

·      Somatic cell nuclear transfer

·      Immunomodulation

·      Cardiac tissue engineering

·      Tissue engineering and biomaterial concepts

·      Challenges to commercialization of tissue engineering products

·      Cell tissue bank

·      Ethics issues in tissue engineering

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track5. Stem cell therapy

Stem Cell Therapy (SCT) is the treatment of various disorders, non-serious to life threatening, by using stem cells. These stem cells can be procured from a lot of different sources and used to potentially treat more than 80 disorders, including neuromuscular and degenerative disorders.  Stem cells from a donor (either from cord blood or bone marrow) are known to reconstitute the defective bone marrow and permanently overcome the disorder.

Degenerative disorders arise from degeneration or wear and tear of bone, cartilage, muscle, fat or any other tissue, cell or organ. This could occur due to a variety of reasons, but it's normally the process known as aging, or 'getting old' that is the biggest cause. The disorders have a slow and insidious onset but once contracted, can be long-standing, pain-staking and lifelong. These disorders can affect any organ of the body. The common degenerative disorders are diabetes, osteoarthritis, stroke, chronic renal failure, congestive cardiac failure, myocardial infarction, Alzheimer's disease, Parkinson's disease etc.

·      Stem cell injection treatment

·      Somatic cell therapy

·      Pluripotent stem cell based cancer therapy

·      Neural stem cells therapy

·      Stem cell therapy for corneal regeneration in the eye

Related Conferences: Endoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track6. Stem cell transplantation

Stem cell transplantation, sometimes referred to as bone marrow transplant, is a procedure that replaces unhealthy blood-forming cells with healthy cells. Stem cell transplantation allows doctors to give large doses of chemotherapy or radiation therapy to increase the chance of eliminating blood cancer in the bone marrow and then restoring normal blood cell production. Researchers continue to improve stem cell transplantation procedures, making them an option for more patients.

The basis for stem cell transplantation is that blood cells (red cells, white cells and platelets) and immune cells (lymphocytes) arise from the stem cells, which are present in marrow, peripheral blood and cord blood. Intense chemotherapy or radiation therapy kills the patient's stem cells. This stops the stem cells from making enough blood and immune cells.

·      Autologous stem cell transplant

·      Allogeneic stem cell transplant

·      Bone marrow transplantation

·      Hematopoietic stem cell transplantation

·      Epithelial transplantation

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track7. Stem cell niche

The stem cell niche is the in vivo microenvironment where stem cells both reside and receive stimuli that determine their fate. Therefore, the niche should not be considered simply a physical location for stem cells, rather as the place where extrinsic signals interact and integrate to influence stem sell behavior. These stimuli include cell-to-cell and cell-matrix interactions and signals (molecules) that activate and/or repress genes and transcription programs. As a direct consequence of this interaction, stem cells are maintained in a dormant state, induced to self-renewal or commit to a more differentiated state.

·      Embryonic erythropoietin niche

·      Adult stem cell niches

·      Mesenchymal stem cells and immunomodulation

·      Atrial cardiac stem cells niche

·      Germline stem cell niches

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track8. Regenerative Medicine

Regenerative medicine is a broad field that includes tissue engineering but also incorporates research on self-healing where the body uses its own systems, sometimes with help foreign biological material to recreate cells and rebuild tissues and organs. The terms “tissue engineering” and “regenerative medicine” have become largely interchangeable, as the field hopes to focus on cures instead of treatments for complex, often chronic, diseases. This field continues to evolve. In addition to medical applications, non-therapeutic applications include using tissues as biosensors to detect biological or chemical threat agents, and tissue chips that can be used to test the toxicity of an experimental medication.  Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering and the production of artificial organs. Regenerative medicine seeks to replace tissue or organs that have been damaged by disease, trauma, or congenital issues, vs. the current clinical strategy that focuses primarily on treating the symptoms. The tools used to realize these outcomes are tissue engineering, cellular therapies, and medical devices and artificial organs.

·      Metal devices and artificial organs

·      Regenerating a new kidney

·      Clinical Translation

·      Prosthodontics and endodontics

·      Periodontal therapy/surgery

·      Advancements in biomedical and tissue engineering techniques

·      Vascular tissue engineering and regeneration

·      Organ transplantation and its new techniques

·      Advanced developments in artificial organ system

·      Regenerative-medicine approach

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track9. Adult stem cells

Adult stem cells, like all stem cells, share at least two characteristics. First, they can make identical copies of themselves for long periods of time; this ability to proliferate is referred to as long-term self-renewal. Second, they can give rise to mature cell types that have characteristic morphologies (shapes) and specialized functions. Typically, stem cells generate an intermediate cell type or types before they achieve their fully differentiated state. The intermediate cell is called a precursor or progenitor cell. Progenitor or precursor cells in fetal or adult tissues are partly differentiated cells that divide and give rise to differentiated cells. Adult stem cells are rare. Their primary functions are to maintain the steady state functioning of a cell-called homeostasis-and, with limitations, to replace cells that die because of injury or disease.

·      Hematopoietic stem cells

·      Mesenchymal stem cells

·      Neural stem cells

·      Induced pluripotent stem cell

·      Trans differentiation

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track10. Embryonic stem cells

Embryonic stem cells are obtained from the inner cell mass of the blastocyst. They can give rise to every cell type in the fully formed body, but not the placenta and umbilical cord. These are incredibly valuable because they provide a renewable resource for studying normal development and disease, and for testing drugs and other therapies. Human embryonic stem cells have been derived primarily from blastocysts. Embryonic stem cells possess the capacity to divide for long periods and retain their ability to make all cell types within the organism. These are termed pluripotent stem cells. The undifferentiated embryonic stem cells are next stimulated to differentiate into the desired type of cell. For this, the cells are allowed to clump together to form embryoid bodies. This helps them differentiate spontaneously. They make nerve cells, heart cells, brain cells, muscle cells and other types of cells.

·      Role of sperm DNA integrity in fertility

·      Fertilization and infertility

·      Embryo implantation

·      Human implantation

·      Atrial cardiac stem cells niche

·      Germline stem cell niches

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track11. Stem cell apoptosis and signal transduction

Self renewal and proliferation of stem cell populations is controlled, in part, by induction of apoptosis. The number of stem cells is therefore a balance between those lost to differentiation / apoptosis and those gained through proliferation. Apoptosis of stem cells is believed to be a dynamic process which changes in response to environmental conditions. For example, the release of stem cell factor inhibits apoptosis following spinal cord injury, presumably in an attempt to promote tissue repair. Dysregulation of apoptosis in stem cells is believed to underlie some cancer pathologies, where apoptotic resistance results in uncontrolled growth (i.e. glioblastoma). Controlling apoptosis is also an important focus for studies of stem cell transplantation, where inhibition may increase the survival of grafted cells during replacement therapy. Harnessing the full therapeutic potential of stem cells will require full elucidation of the signal transduction cascades for proliferation, differentiation, and apoptosis.

·      Specific cancer immunotherapy

·      Translational studies for cancer stem cell-based therapies

·      Ubiquitination pathways for cancer therapy

·      Specific cancer immunotherapy

·      Epigenetics and cancer stem cells

·      Novel therapeutics

·      Apoptosis and hematopoietic stem cells

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track12. Computational biology in stem cells

Computational biology, a branch of biology involving the application of computer science to the understanding and modeling of the structures and processes of biology, that referred to as bioinformatics. It entails the use of computational methods for the representation and apply advanced analysis techniques that make it possible to dissect complex collections of data from a wide range of technologies and sources.

The fields of stem cell biology and regenerative medicine research are fundamentally about understanding dynamic cellular processes such as development, reprogramming, repair, differentiation and the loss, acquisition or maintenance of pluripotency. Whereas bioinformatics is used to interpret the information produced by such technologies. In order to precisely decipher these processes at a molecular level, it is critical to identify and study key regulatory genes and transcriptional circuits. Modern high-throughput molecular profiling technologies provide a powerful approach to addressing these questions as they allow the profiling of tens of thousands of gene products in a single experiment. Whereas bioinformatics is used to interpret the information produced by such technologies.

·      Bioinformatic analysis of stem cells

·      Bio robotics and biosensors

·      Gene expression analysis

·      Computational Tools for Stem Cell Biology

·      Cellular computing and drug discovery

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track 13. Epigenetics

Epigenetics is the study of potentially heritable changes in gene expression that does not involve changes to the underlying DNA sequence - a change in phenotype without a change in genotype -which in turn affects how cells read the genes. Gene expression can be controlled through action of repressor protein that attach to silencer regions of DNA. Many types of epigenetic processes have been identified-they include methylation, acetylation, phosphorylation, ubiquitylation, and sumolyation. Other epigenetic mechanisms and considerations are likely to surface as work proceeds. Epigenetic processes are natural and essential to many organism functions, but if they occur improperly, there can be major adverse health and behavioral effects. One example of an epigenetic change in eukaryotic biology is the process of cellular differentiation. During morphogenesistotipotent stem cells become the various pluripotent cell lines of the embryo, which in turn become fully differentiated cells. In other words, as a single fertilized egg cell - the zygote - continues to divide, the resulting daughter cells change into all the different cell types in an organism, including neurons, muscle cells, epithelium, endothelium of blood vessels, etc., by activating some genes while inhibiting the expression of others.

·            Gene silencing

·            DNA methylation and genomic imprinting

·            Single-cell technology in cancer research

·            Stem cell epigenetics and disease

 

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track 14. Biobanking

biobank is a type of biorepository that stores biological samples (usually human) for use in research. The wide array of bio specimens (including blood, saliva, plasma, and pure DNA) maintained in biobanks is delineating as libraries of the human organism. They’re rigorously characterized to see the final and distinctive options of the continual cell line and therefore the absence or presence of contaminants, thus establishing a basic understanding regarding the staple from that the biological product is being derived and maintained. Biobanks have become an important resource in medical research, supporting many types of contemporary research like genomics and personalized medicine. For example, many diseases are associated with single-nucleotide polymorphisms, and performing genome-wide association studies using large collections of samples which represent tens or hundreds of thousands of individuals can help to identify disease biomarkers. Many researchers struggled to acquire sufficient samples prior to the advent of biobanks.

·      Identification of Genetic Variation or SNPs

·      Integrating Biobanks

·      Data Systems and Records Management

·      Sample Storage and Distribution Management System

·      Cell tracking and tissue imaging

·      Hematopoietic stem cells

·      Blastocyst Complementation

·      3D Bio printing

·      Next generation biobanking

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track15. Biobank ethics

Ethical issues are commonly present in many aspects of Biobanking. The fact that Bio banks deal with human samples, invading an individual autonomy or limiting self-control, provokes a number of ethical issues. Who is actually competent to give informed consent and donate a sample? When individuals donate part of their body to a bio bank, how is that human sample processed? Who is the owner of the sample? Who should decide how it should be used? Who has the right to know individual results of research? These and many more ethical dilemmas exist in the ethical framework of bio banks. With the recent rapid developments in Biobanking, all of these issues are magnified with plenty of further new questions continuously arising. Ethical framework has been the most controversial issue in the domain of bio banking. Thus, it is not surprising that there is a substantial literature focusing on ethical dilemmas in bio banking, such as informed consent, privacy, protection, and returning of results to participants. For many years, researchers at CRB have provided constructive advice on how to deal with ethical aspects of research using human tissue material and personal data. For more than 80 years tissue has been derived from human bodies, stored, distributed and used for therapeutic, educational, forensic and research purposes as part of healthcare routine in most western countries.

·      Virtual Biobanks 

·      Tissue Banks 

·      Hematopoietic stem cell bank

·      Umbilical cord blood banks

·      Ethical and legal Issues

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track16. Stem cell in drug development

Stem cell therapy has opened a new avenue in the area of drug discovery and development. Biopharmaceutical companies have been working in deciphering vital applications of stem cell technologies in the drug development processes so as to reduce the high attrition rate of late stage drug candidates, which has been growing at a fast pace in the past decade. Advent of stem cell technologies has provided new prospects to build innovative cellular models. The constantly evolving methodologies used for isolation of human/animal embryonic stem cells (ESCs), bone marrow-derived mesenchymal stem cells, umbilical cord stem cells, adult tissue-specific neural stem cells and human induced pluripotent stem cells (iPSC) have led to the advancement of numerous high throughput and combinatorial screening technologies thus supplementing the role of stem cell models in drug discovery

·      Cancer clinical trails

·      Clinical research and bioethics

·      Drug screening tools

·      Stem cell biology and regenerative medicine

·      Drug safety and regulations

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track17. Cell and gene therapy

Cell therapy or cryotherapy is the transfer of cells into a patient with a goal of improving the disease.  From beginning blood transfusions were considered to be the first type of cell therapy to be practiced as routine. Later, Bone marrow transplantation has also become a well-established concept which involves treatment of much kind of blood disorders including anemia, leukemia, lymphoma and rare immunodeficiency diseases. Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery. cell and gene Therapies have made vital therapeutic advances in less than three decades. Inside this brief span traverse, both gene and cell treatments have investigated numerous ideas, created different innovations, surveyed the advances in various animal models, and tried the novel treatments in numerous human clinical trials of dreaded infections. Some energizing changes have been seen in a few infections by the medications. Although a few trials did not give the hope for advancements, every trial has propelled our comprehension of the complex interactions between various tissues and highlighted challenges for further research.

·      Gene Therapy and Genetic Engineering

·      Somatic Gene Therapy

·      Germ Line Gene Therapy

·      Cell Cancer Immunotherapy

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track18. Stem cell biomarkers

Bio marker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A bio marker may be used to see how well the body responds to a treatment for a disease or condition. In cancer research and medicine, bio markers are used in three primary ways:

·      To help diagnose conditions, as in the case of identifying early stage cancers (Diagnostic)

·      To forecast how aggressive a condition is, as in the case of determining a patient's ability to fare in the absence of treatment (Prognostic)

·      To predict how well a patient will respond to treatment (Predictive)

 

·      Cancer Stem Cell Biomarkers

·      Trophoblast Stem Cell Biomarkers

·      Cardiac Stem Cell Biomarkers

·      Hematopoietic Stem Cell Biomarkers

·      Skin Stem Cell Markers

·      Retinal Stem Cell Markers

Related ConferencesEndoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

Track19. Stem cell nanotechnology

Human beings suffer from a myriad of disorders caused by biochemical or biophysical alteration of physiological systems leading to organ failure. For a number of these conditions, stem cells and their enormous reparative potential may be the last hope for restoring function to these failing organ or tissue systems. To harness the potential of stem cells for biotherapeutic applications, we need to work at the size scale of molecules and processes that govern stem cells fate. Nanotechnology provides us with such capacity. Therefore, effective amalgamation of nanotechnology and stem cells - medical nanoscience or nanomedicine - offers immense benefits to the human race. stem cell nanotechnoogy research focuses   on several important areas such as stem cell visualization and imaging, genetic modifications and reprogramming by gene delivery systems, creating stem cell niche, and similar therapeutic applications.

·      Mesenchymal stem cells and Nano-structured surfaces
DNA nanotechnology

·      Engineering of a 3D nanostructured scaffold

·      Stem cell mobilization

Related Conferences: Endoderm Development and Disease conference, February 25-March 1, 2018, New Mexico, USA. From Stem Cells to Human Development conference, 25–28 Sept 2018, Massachusetts, US. iPSC-Based Disease served World Congress on Organ Transplantation and Artificial Organs conference, April 23- 24, 2018, Dubai, UAE. Tissue Science and Regenerative Medicine conference, May 10-11, 2018 Frankfurt, Germany. 20th International Conference on Epigenetics, Chromatin and Transcription Conference, 08–09 Jan 2018, Singapore. Cancer Epigenetics: New mechanisms, New therapies Conference, 10–14 Feb 2018, Breckenridge, US.

Related societies and association:  Motor Neuron Diseases AssociationTaiwan Society for Stem Cell Research, Danish Stem Cell SocietyStem Cell Society SingaporeNorwegian Centre For Stem Cell ResearchHelmholtz Association Biobank GermanyBrain Bank for Aging Research (Japan)Australian Brain Bank Network (ABBN)Australasian Bio specimen Network (ABN).

 

 

 

 

Market Analysis

 

11th World Congress on Stem Cell and Biobanking

Success of the 9th Cell Science conferences series has given us the prospect to bring the gathering one more time for our 11th World Congress on Stem Cell and Biobanking 2018 meet in August 20-21, 2018 Tokyo, Japan. Since its commencement in 2011 cell science series has perceived around 750 researchers of great potentials and outstanding research presentations around the globe. The awareness of stem cells and its application is increasing among the general population that also in parallel offers hope and add woes to the researchers of cell science due to the potential limitations experienced in the real-time. 

Stem Cell Biology 2018 has the goal to fill the prevailing gaps in the transformation of this science of hope to promptly serve solutions to all in the need. Stem Cell Biology 2018 will have an anticipated participation of 100-120 delegates from around the world to discuss the conference goal. 

History of stem cells research        

Stem cells have an interesting history; in the mid 1800s, it was revealed that cells were basically the building blocks of life and that some cells had the ability to produce other cells. Efforts were made to fertilize mammalian eggs outside of the human body and in the early 1900s, it was discovered that some cells had the capacity to generate blood cells. In 1968, the first bone marrow transplant was achieved successfully to treat two siblings with severe combined immunodeficiency. Other significant events in stem cell research include:

1978: Stem cells were discovered in human cord blood
1981: First in vitro stem cells line developed from mice
1988: Embryonic stem cells lines created from a hamster
1995: First embryonic stem cells line derived from a primate
1997: Cloned lamb from stem cells
1997: Leukemia origin found as haematopoietic stem cells, indicating possible proof of cancer stem cells

Members Associated with Stem Cells Research

Discussion on Development, Regeneration, and Stem Cells Biology takes an interdisciplinary approach to understanding the fundamental question of how a single cell, the fertilized egg, ultimately produces a complex fully patterned adult organism, as well as the intimately related question of how adult structures regenerate. Stem cells play critical roles both during embryonic development and in later renewal and repair. More than 65 faculties in Philadelphia from both basic science and clinical departments in the Division of Biological Sciences belong to Development, Regeneration, and Stem Cells Biology. Their research uses traditional model species including nematode worms, fruit-flies, Arabidopsis, zebrafish, amphibians, chick and mouse as well as non-traditional model systems such as lampreys and cephalopods. Areas of research focus include stem cell biology, regeneration, developmental genetics, and cellular basis of development, developmental neurobiology, and “evo-devo” (Evolutionary developmental biology).

Stem Cell Market Value

Worldwide many companies are developing and marketing specialized cells culture media, cells separation products, instruments and other reagents for life sciences research. We are providing a unique platform for the discussions between academia and business.

Global Tissue Engineering & Stem Cell Therapy Market, By Region, 2009 2018

 

https://d2cax41o7ahm5l.cloudfront.net/cs/upload-images/stemcell-asiapacific-2017-84251.png

Why to attend???

Stem Cell Research-2017 could be an outstanding event that brings along a novel and International mixture of researchers, doctors, leading universities and stem cell analysis establishments creating the conference an ideal platform to share knowledge, adoptive collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in cell science fields are assurances of this conference. 

A Unique Opportunity for Advertisers and Sponsors at this International event:

Website URL: http://stemcell.geneticconferences.com/

UAS Major Universities which deals with Stem Cell Research 

·  University of Washington/Hutchinson Cancer Center

·  Oregon Stem Cell Center

·  University of  California Davis

·  University of  California San Francisco

·  University of California Berkeley

·  Stanford University

·   Mayo Clinic

Major Stem Cell Organization Worldwide:

·  Norwegian Center for Stem Cell Research

·  France, I-stem

·  Stem Cell & Regenerative Medicine Ctr, Beijing

·  Stem Cell Research Centre, Korea

·  NSW Stem Cell Network

·  Monash University of  Stem Cell Labs

·  Australian Stem Cell Centre

Target Audience:

Academic personales, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cell research, stem cell line companies can be as Target Audience

Market Analysis of Stem Cell Therapy:

The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.

Americas is the largest region of global stem cells market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018

Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.

 

https://d2cax41o7ahm5l.cloudfront.net/cs/upload-images/stemcell-asiapacific-2017-86733.png

Figure 2: Global Market

Companies working for Stem Cell:

Company

Location

Business Type

Cynata Therapeutics

Armadale, Australia

Stem Cell Manufacturing Technology

Mesoblast

Melbourne, Australia

Regenerative Medicine

Activartis

Vienna, Austria

Dendritic Cell-Based Cancer Immunotherapy

Aposcience

Vienna, Austria

Treatments composed of mixture of cytokines, growth factors and other active components

Cardio3 Biosciences

Mont-Saint-Guibert, Belgium

Stem Cell Differentiation

Orthocyte (BioTime)

Alameda, CA

Cellular Therapies

Capricor

Beverly Hills, CA

Stem Cell Heart Treatments

Life Stem Genetics

Beverly Hills, CA

Autologous stem cell therapy

International Stem Cell

Carlsbad, CA

Proprietary Stem Cell Induction

Targazyme

Carlsbad, CA

Cell Therapy

DaVinci Biosciences

Costa Mesa, CA

Cellular Therapies

Invitrx Therapeutics

Irvine, CA

Autologous Stem Cell Therapy, Therapeutic & Cosmetic

 

Stem Cell Software’s:

  1. Cryus: Cryus is developed specially for Cord Blood Banks, Donor Centers, Stem Cells Collection Centers, Biotech Laboratories and Tissue Banks.
  2. Label-InnThe: Which allows to record the donor or the patient personal data into the database and generates the Donation Identification Number (DIN) according to ICCBBA international standard ISBT128. It serves as labelling software for blood samples and Stem Cells products.

Products Manufactured by Industry Related to Stem Cell:

RoboSep™-16 is the latest RoboSep™ instrument ingenuous for performing fully-automated cell separation from a huge number of samples. Using EasySep™, the column-free immunomagnetic cell separation system, RoboSep™-16 isolates desired cells from a wide range of samples from different species, tissue sources or sizes using positive or negative selection. Through an intuitive user interface, the RoboSep™-16 simultaneously isolates cells from up to sixteen samples with minimal hands on time. By automating all reagent and sample handling steps, and through the use of disposable pipette tips, the RoboSep™-16 rapidly isolates all desired cells while minimizing the risk of sample cross-contamination. After completion of the cell isolation procedure, cells of interest are immediately available for any downstream application.

The EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Kit is designed to isolate highly purified CD25+ cells from single cell suspensions of splenocytes or other tissues by positive selection. Desired cells are labeled with antibodies and magnetic particles.  The cells are separated without columns using an EasySep™ magnet.  Unwanted cells are simply poured off, while desired cells remain in the tube.  Isolated cells are immediately ready for downstream applications such as flow cytometry, cell culture, or suppression assays.

Featured Research:

Gene therapy gives assurance for severe combined immunodeficiency, Researchers have initiated that gene therapy using an improved delivery system, or vector, can restore the immune systems of children with X-linked severe combined immunodeficiency (SCID-X1), a rare, life-threatening inherited condition that primarily affects boys. Previous efforts to treat SCID-X1 with gene therapy were initially efficacious, but approximately one-quarter of the children developed leukemia two to five years after treatment. Results from a study partially funded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), suggest that the new vector is equally effective at restoring immunity and may be safer than previous approaches.

References:

 http://www.stemcell.com/en/Products/All-Products/EasySep-Mouse-CD25-Regulatory-T-Cell-Positive-Selection-   Kit.aspx

  1. http://www.stemcell.com/en/Products/All-Products/EasySep-Mouse-CD25-Regulatory-T-Cell-Positive-Selection-Kit.aspx
  2. http://seekingalpha.com/article/1347281-investing-in-the-stem-cell-sector-an-overview
  3. http://mbbnet.umn.edu/scmap/scresearchmap.html
  4. http://biopharmguy.com/links/company-by-location-stem-cells.php
  5. http://www.marketwired.com/press-release/latest-research-shows-stem-cell-product-market-to-reach-6-billion-by-2016-1688406.htm

 

 

Past Conference

Past Conference Report

The success of the 7th Cell Science conference has given us the prospect to bring the gathering one more time. Conferences series LLC hosted the “8th World Congress and Expo on Cell and Stem Cell Research” during March 20-22, 2017 at Hotel Holiday Inn, Orlando Airport, Orlando, Florida, USA. The conference was focused on Cell Biology and Stem Cell Research studies with the theme “Explore and Exploit the Novel Techniques in Cell and Stem Cell Research”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like Stem Cell Therapy, Drugs and Clinical Developments, Stem Cell Transplantation, Current Research, Research and Development: Instrumentation, Genetics & Genomics, Cell based Therapies of Blood Diseases: Malignant and Non-Malignant & Cell Line Development, Novel Stem Cell Technologies, Cell Mechanics, Apoptosis and Cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

Paul J. Davis, Albany Medical College, USA

Haval Shirwan, University of Louisville, USA

Diana Anderson, University of Bradford, UK

Georg F. Weber, University of Cincinnati, USA

Bakhos A Tannous, Harvard Medical School, USA

Mahendra S.Rao, Q Therapeutics, Inc., USA

Best Poster Awardees:

Title: Effect of ionizing radiation on the proliferation of human embryonic stem cells

Irina V Panyutin, National Institute of Health, USA

Title: Manipulation of adult stem cells plasticity with modulators of chromatin modifying enzymes

Arshak R Alexanian, Cell Reprogramming & Therapeutics LLC, USA

Conferences series LLC hosted the “9 th annual conference on Stem Cell and Regenerative Medicine ” during Sep 25-26, 2017 Berlin, Germany. The conference was focused with the theme “Frontiers in Stem Cells & Regeneration Medicine”

The meeting engrossed a vicinity of comprehensive discussions on novel subjects like Stem cell, Stem cell therapy, Stem cell treatment, Somatic cell therapy, Tissue regeneration, Regeneration and therapeutics, Tumour cell science, Cell and gene therapy, Stem cell biomarkers, Stem cell nanotechnology, Stem cell bioinformatics, Biomaterial engineering.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

Y James Kang, Sichuan 3D Bio-printing Institue, China

Title: Vascular tissue regeneration from implantation of 3D bio-printed stem cell grafts in rhesus monkeys

Viacheslav M Mikhailov, Institute of Cytology - Russian Academy of Sciences, Russia

Title: Cell transplantation as tool for foetuses growth regulation

Helen McGettrick, University of Birmingham, UK

Title: Adipogenic differentiation of MSC alters their immunomodulatory properties in a tissue-specific manner

Jasbir Rattu, CeutiQus Limited, UK

Title: Maximizing Integrated Quality (IQ) in Advanced Therapy Medicinal Products (ATMPs) and regenerative medicines

Luca Gentile, Fraunhofer Institute, Germany

Title: The Heartpatch, an alginate-based scaffold system for cardiac tissue engineering

Conferenceseries LLC offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with the organisation and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Stem Cell Research-2017, Conference series LLC would like to announce the commencement of the “11th  World Stem Cell And Biobanking” to be held in August 2018 at Tokyo, Japan. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cell Science Research.

For more details: http://stemcell.geneticconferences.com/

Let us meet again @ Stem Cell Biobanking 2018

 

 

 

 

To Collaborate Scientific Professionals around the World

Conference Date August 20-21, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Stem Cell Research and Therapy Journal of Cell Science and Therapy Cell and Development Biology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by